Deng Kehong, Xu Chang, He Qing, Safdar Muhammad, Nazar Mudassar, Li Xiaocong, Li Kun
Department of Pharmacy, Hubei Three Gorges Vocational and Technical College, Yichang 443000, China.
College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210095, China.
Vet Sci. 2025 Apr 10;12(4):354. doi: 10.3390/vetsci12040354.
This study aims to explore the therapeutic potential of Radix (APR), a traditional Chinese medicine that is widely known for its anti-inflammatory, anti-oxidative, and anti-microbial properties, using a mouse model. In this study, 30 mice were selected and divided into three groups: control group (CD), infection group (ED), and treatment group (TD). Mice in the TD were gavaged with APR oil (0.15 mL/kg/day) for 20 days, while mice in the CD and ED received an equal volume of normal saline. On the 21st day, mice in the ED and TD were infected with multi-drug-resistant (1 × 10 CFU/mL) derived from diarrheal yak. Twenty-four hours later, all mice were euthanized, and blood, organs, and intestinal samples were collected for analysis. The results of intestinal sections and intestinal bacterial load revealed that APR treatment significantly reduced ( < 0.05) both bacterial load and intestinal injury. Serum analysis indicated that APR treatment also alleviated the inflammation and oxidative stress induced by infection. Intestinal microbiota sequencing further showed that APR treatment increased the abundance of intestinal probiotics such as , , and while also enhancing the enrichment of functional pathways associated with antioxidant defense. In conclusion, APR treatment effectively alleviates diseases caused by infection, promotes the growth of beneficial intestinal bacteria, and improves the antioxidant capacity in animals. Additionally, these findings confirm APR's role in addressing immediate effects rather than chronic adaptations. Future studies should investigate the prolonged effects of APR treatment beyond the acute phase.
本研究旨在利用小鼠模型探索红芪(APR)的治疗潜力,红芪是一种以抗炎、抗氧化和抗菌特性而广为人知的传统中药。在本研究中,选取30只小鼠并分为三组:对照组(CD)、感染组(ED)和治疗组(TD)。治疗组的小鼠每天灌胃给予红芪油(0.15 mL/kg/天),持续20天,而对照组和感染组的小鼠给予等量的生理盐水。在第21天,感染组和治疗组的小鼠感染源自腹泻牦牛的多重耐药菌(1×10 CFU/mL)。24小时后,对所有小鼠实施安乐死,并采集血液、器官和肠道样本进行分析。肠道切片和肠道细菌载量的结果显示,红芪治疗显著降低了(<0.05)细菌载量和肠道损伤。血清分析表明,红芪治疗还减轻了由感染诱导的炎症和氧化应激。肠道微生物群测序进一步表明,红芪治疗增加了诸如、和等肠道益生菌的丰度,同时还增强了与抗氧化防御相关的功能途径的富集。总之,红芪治疗有效减轻了由感染引起的疾病,促进了有益肠道细菌的生长,并提高了动物的抗氧化能力。此外,这些发现证实了红芪在解决即时效应而非慢性适应性方面的作用。未来的研究应调查红芪治疗在急性期之后的长期影响。